Indoco Remedies Ltd.

NSE: INDOCO | BSE: 532612 | ISIN: INE873D01024 | Industry: Pharmaceuticals
| Slowing Down Stock
229.6600 -2.91 (-1.25%)
NSE May 02, 2025 15:31 PM
Volume: 29,178
 

229.66
-1.25%
ICICI Securities Limited
ICICI Securities Ltd | Retail Equity Research Revenues grew 10% YoY to | 281 crore (I-direct estimate: | 307 crore) mainly due to 22% growth in domestic formulations to | 169 crore. Export formulation grew 6% YoY to | 98 crore EBITDA margins fell 302 bps YoY to 14.9% (I-direct estimate: 17.7%) mainly due to an increase in employee cost and other expenditure. EBITDA fell 8% to | 42 crore (I-direct estimate: | 54 crore) Net profit declined 2% YoY to | 22 crore (I-direct estimate: | 30...
Indoco Remedies Ltd. is trading below all available SMAs
More from Indoco Remedies Ltd.
Recommended